Yujia Zhou

Yujia Zhou

Auto-generated profile, based on publicly available information

Yujia Zhou

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
YZYujia Zhou
Yujia Zhou
CPChristopher M. Pruet
Christopher M. Pruet
CFChengbo Fang
Chengbo Fang
CKCheryl L. Khanna
Cheryl L. Khanna

8 August 2024 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
YZYujia Zhou
Yujia Zhou
ABAmanda K. Bicket
Amanda K. Bicket
SMShikha Marwah
Shikha Marwah
JSJoshua D. Stein
Joshua D. Stein
KKKrishna S. Kishor
Krishna S. Kishor
CAChris Andrews
Chris Andrews

1 September 2021 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
YZYujia Zhou
Yujia Zhou
MSMichael J. Shapiro
Michael J. Shapiro
Barbara K. BurtonBarbara K. Burton
Barbara K. Burton
MMMarilyn B. Mets
Marilyn B. Mets
SKSudhi Pullat Kurup
Sudhi Pullat Kurup
Norrie disease is a rare X-linked recessive vitreoretinopathy. Variants of the NDP gene are associated with this condition. This case reports aims to demonstrate the variations of clinical presentations and exam findings of this disease. A retrospective chart review of the patient's ocular and systemic findings and imaging results was performed. The patient had received genetic testing, including mutational analysis of targeted genes associated with retrolental masses. The patient had a comprehensive eye exam for bilateral leukocoria, demonstrating large retrolental masses, anterior polar cataracts, stretched ciliary processes, and roving eye movements. B-scan ultrasonography and magnetic resonance imaging indicated total, funnel-shaped retinal detachments, which is a unique retinal configuration in Norrie disease. Genetic testing confirmed deletion of the coding region of all three exons in the NDP gene, which confirmed Norrie disease. He has not shown any extraocular involvement to date. This is a case demonstrating the association between deletion of the coding region NDP gene and Norrie disease. The phenotypical variation of this disease warrants further studies of genotype-phenotype correlations and mutations of the NDP gene.

30 August 2022 in Journal of Current Glaucoma Practice
Verified
Journal Article
Open access
YZYujia Zhou
Yujia Zhou
SCSydni Coleman
Sydni Coleman
JBJess Boysen
Jess Boysen
MPMorgan L Pansegrau
Morgan L Pansegrau
MWMartha M Wright
Martha M Wright
KAKaren Armbrust
Karen Armbrust
The study purpose was to assess patient survival after tube shunt implant or cyclodestructive procedure for neovascular glaucoma and to determine whether specific preoperative factors are predictive of survival. A retrospective chart review was performed on patients with neovascular glaucoma who underwent tube shunt implant and/or cyclodestructive procedure between January 2002 and December 2019 at the Minneapolis Veterans Affairs Health Care System. Patient survival was compared to the age and gender-matched Minnesota population. Cox regression analyses were performed to evaluate preoperative parameters and survival. Tube shunt alone was implanted in 30 eyes, cyclodestruction alone was performed in nine eyes, and two eyes underwent both (n = 41 eyes, 39 patients). The postoperative 5-year survival rate was 62% in neovascular glaucoma patients compared to 80% in controls. Survival did not differ significantly based on neovascular glaucoma etiology. Preoperative best-corrected visual acuity of the neovascular glaucoma-affected eye (p = 0.05) and Charlson Comorbidity Index (p = 0.02) were associated with survival, but preoperative maximum intraocular pressure, hemoglobin A1c, and creatinine were not. The mean intraocular pressure at 6 months postprocedure was 14 mm Hg for tube shunt and 27 mm Hg for cyclodestruction (p = 0.03). Neovascular glaucoma patients have reduced survival, but the majority survived at least 5-year postprocedure. Ophthalmologists should consider patient survival and factors predictive of survival when planning procedures for neovascular glaucoma. Our findings provide an updated perspective on survival in the setting of neovascular glaucoma and can help ophthalmologists provide patient-centered and holistic care. Zhou Y, Coleman S, Boysen J, et al. Survival in Patients with Neovascular Glaucoma Following Tube Shunt Implant or Cyclodestructive Procedure. J Curr Glaucoma Pract 2022;16(2):74-78.